BB BIOTECH N/ CH0038389992 /
08/10/2024 17:30:17 | Diferencia +0.350 | Volumen | Bid8:30:00 | Ask8:30:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.350CHF | +0.97% | 46,618 Volumen de negocios: 1.68 millones |
36.000Volumen de oferta: 149 | -Tamaño/ Volumen/ Formato de Ask: 522 | 2.01 mil millonesCHF | 5.50% | - |
Newsfile Corp
5:03
CXM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sprinklr, Inc. Investors with Losses in...
Newsfile Corp
4:04
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PD...
Newsfile Corp
3:18
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of St...
Newsfile Corp
3:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Impo...
Newsfile Corp
2:45
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WE...
Newsfile Corp
2:41
Spire Global (SPIR) Secures Debt Waiver Amid Accounting Scandal and Investor Suit- Hagens Berman
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página